| 000 | 01758 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513185255.0 | ||
| 264 | 0 | _c19990729 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRongcun, Y | |
| 245 | 0 | 0 |
_aIdentification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJul 1999 |
||
| 300 |
_a1037-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aCarcinoma _xgenetics |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 | _aColonic Neoplasms |
| 650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aMelanoma _xgenetics |
| 650 | 0 | 4 |
_aOligopeptides _xchemical synthesis |
| 650 | 0 | 4 | _aOvarian Neoplasms |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xbiosynthesis |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aSalazar-Onfray, F | |
| 700 | 1 | _aCharo, J | |
| 700 | 1 | _aMalmberg, K J | |
| 700 | 1 | _aEvrin, K | |
| 700 | 1 | _aMaes, H | |
| 700 | 1 | _aKono, K | |
| 700 | 1 | _aHising, C | |
| 700 | 1 | _aPetersson, M | |
| 700 | 1 | _aLarsson, O | |
| 700 | 1 | _aLan, L | |
| 700 | 1 | _aAppella, E | |
| 700 | 1 | _aSette, A | |
| 700 | 1 | _aCelis, E | |
| 700 | 1 | _aKiessling, R | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 163 _gno. 2 _gp. 1037-44 |
|
| 999 |
_c10353986 _d10353986 |
||